堃博医疗控股有限公司（02216）于2026年2月5日发布2026年1月股份变动月报。报告期为截至2026年1月31日止的一个月。
本月内公司法定股本未发生变化，维持2,000,000,000股普通股注册，面值每股USD 0.000025，总注册股本继续保持USD 50,000。
截至1月底，公司已发行普通股（不含库存股份）由上月底的526,579,084股增至527,079,084股，增加500,000股；库存股份数目维持1,658,000股不变，合计已发行股份总数为528,737,084股。公司本月无股份回购或注销行为。
根据月报披露，本月内行使的股票期权来自此前于2021年5月9日采纳的股份激励计划，共行使500,000股期权，带来行使资金总额约HKD 671,299.99。
董事会表示，公司截至本月末仍符合香港联交所关于公众持股量的要求，亦已遵守相关上市规则及法律规定，且所有股份发行均经正式授权批准。公告由公司董事徐宏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.